Fructose Intestinal Gluconeogenesis Study

This study is looking at how your body handles fructose, a type of sugar. Researchers want to understand if your small intestine's ability to turn fructose into glucose (a process called gluconeogenesis) helps protect your liver. They are also investigating if this protective effect is different in people with obesity. You might be eligible if you are a healthy adult between 20 and 55 years old, with a BMI (Body Mass Index) that is either in the healthy range (19-25 kg/m2) or the obese range (30-38 kg/m2). The study involves consuming liquid meals with different amounts of fructose and special tracers (13C labeled fructose) given by mouth and intravenously (into a vein). The main goal is to measure how much fructose is converted to glucose in different parts of your body over 6 hours. The current status of this study is unclear.

Study design
This interventional study plans to enroll 40 healthy participants, including those with obesity. Participants will undergo four separate outpatient feeding studies in a crossover fashion.
What's involved
You will have a sugar tolerance test at the start. Then, you will have four separate visits, about three weeks apart, where you will fast overnight, consume liquid meals with tracers, and have blood and urine samples collected frequently over six hours.
Compensation
Not stated in the trial record.
Follow-up
The primary measurements for this study are taken at 6 hours after the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07209202

Fructose Intestinal Gluconeogenesis

Recruiting
NAAges 20–55InterventionalBasic science
Touro University, California
~40 participants
Updated 2026-03-06 on ClinicalTrials.gov
What's tested:High fructose mealLow fructose meal13C labeled fructose, oral13C labeled fructose, intravenous

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Fru-GNG
Measured over 6 hours
+3 more outcomes measured
Healthy Participants
Obese But Otherwise Healthy Participants
1 sites across 1 states
California1
  • Jean-Marc Schwarz, PhD · PRINCIPAL_INVESTIGATOR · Touro University, California
  • Grace M Jones, PhD · PRINCIPAL_INVESTIGATOR · Touro University, California

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

BMI 30 to 38 kg/m2 (obese group) or BMI 19 to 25 kg/m2 (lean group)

Exclusion

Pregnancy or lactation within the past six months;
Type 1 or 2 diabetes mellitus (including fasting glucose ≥126 mg/dL, HgbA1c ≥6.5%);
History of liver disease or AST and ALT 2x above the upper limit of normal;
Fasting triglyceride \> 300 mg/dl; total cholesterol levels above the 95th percentile for age and sex;
Hemoglobin (Hgb) \<12.5g/d or hematocrit\<3x Hgb value;
Report of HIV or hepatitis B or C infection;
History of cancer, other than basal cell or squamous cell carcinoma or kidney disease stage 3 or higher or patients currently on dialysis;
Use of any anti-diabetic medications or hypolipidemic agents in the past six months;
History of surgical procedure for obesity;
Change in body weight \>5% in the past six months (by self-report);
History of other conditions known to affect insulin sensitivity and lipid metabolism (e.g., polycystic ovary syndrome), history of galactosemia, hereditary fructose intolerance, or who test positive for fructose malabsorption at screening;
Known intolerance to acetaminophen.
  • Fru-GNG6 hours

    Total amount of fructose converted to glucose

  • Fru-hGNG6 hours

    Amount of fructose converted to glucose in the liver

  • Fru-iGNG6 hours

    Amount of fructose converted to glucose in the intestine

  • De novo lipogenesis (DNL)6 hours

    Percent of newly synthesized palmitate